Edition:
United States

AmerisourceBergen Corp (ABC.N)

ABC.N on New York Stock Exchange

98.42USD
23 Feb 2018
Change (% chg)

$1.30 (+1.34%)
Prev Close
$97.12
Open
$97.57
Day's High
$98.49
Day's Low
$96.67
Volume
363,970
Avg. Vol
457,660
52-wk High
$106.26
52-wk Low
$71.90

Latest Key Developments (Source: Significant Developments)

Walgreens In Early-Stage Talks To Buy AmerisourceBergen- CNBC,Citing DJ
Monday, 12 Feb 2018 05:36pm EST 

Feb 12 (Reuters) - :WALGREENS IN EARLY-STAGE TALKS TO BUY AMERISOURCEBERGEN, OF WHICH IT ALREADY OWNS 26 PERCENT - CNBC,CITING DJ.  Full Article

Amerisourcebergen Reports Fiscal 2018 First Quarter Results
Tuesday, 6 Feb 2018 06:30am EST 

Feb 6 (Reuters) - Amerisourcebergen Corp ::AMERISOURCEBERGEN REPORTS FISCAL 2018 FIRST QUARTER RESULTS.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $6.45 TO $6.65.Q1 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.55 EXCLUDING ITEMS.Q1 GAAP EARNINGS PER SHARE $3.90.REVENUES OF $40.5 BILLION FOR Q1, A 6.0 PERCENT INCREASE YEAR-OVER-YEAR.AMERISOURCEBERGEN - ADJUSTED EARNINGS PER SHARE BENEFIT FROM U.S. TAX REFORM IS EXPECTED TO BE ABOUT $0.60 IN FISCAL 2018.SEES 2018 ‍ADJUSTED DILUTED EARNINGS PER SHARE TO BE IN RANGE OF $6.45 TO $6.65​.SEES 2018 ‍REVENUE GROWTH IN RANGE OF 8 PERCENT TO 11 PERCENT​.AMERISOURCEBERGEN - "REMAIN CONFIDENT IN PHARMEDIUM'S ABILITY TO RETURN TO ITS LONG-TERM GROWTH TRAJECTORY".SEES 2018 ‍CAPITAL EXPENDITURES OF APPROXIMATELY $325 MILLION​.Q1 EARNINGS PER SHARE VIEW $1.35, REVENUE VIEW $40.50 BILLION -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $6.29, REVENUE VIEW $166.80 BILLION -- THOMSON REUTERS I/B/E/S.AMERISOURCEBERGEN - CONTINUES TO OPERATE UNDER ASSUMPTION THAT BRAND DRUG INFLATION WILL BE IN RANGE OF 6 PERCENT TO 7 PERCENT FOR PHARMACEUTICAL MARKET IN 2018.AMERISOURCEBERGEN - CONTINUES TO OPERATE UNDER ASSUMPTION THAT GENERIC DRUG DEFLATION WILL BE IN RANGE OF -7 PERCENT TO -9 PERCENT FOR PHARMACEUTICAL MARKET IN 2018.  Full Article

AmerisourceBergen Announces Operating Commitments to Address Opioid Diversion And Abuse
Thursday, 7 Dec 2017 08:00am EST 

Dec 7 (Reuters) - Amerisourcebergen Corp ::AMERISOURCEBERGEN ANNOUNCES OPERATING COMMITMENTS TO ADDRESS OPIOID DIVERSION AND ABUSE.AMERISOURCEBERGEN - WILL CONTINUE TO REPORT QUANTITY, RECEIVING PHARMACY OF ALL ORDERS OF OPIOID-BASED MEDICINES TO DRUG ENFORCEMENT AGENCY ON DAILY BASIS.  Full Article

AmerisourceBergen Prices $750 Mln 3.45 Pct Senior Notes Due 2027
Wednesday, 29 Nov 2017 05:16pm EST 

Nov 29 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN PRICES $750 MILLION 3.45% SENIOR NOTES DUE 2027 AND $500 MILLION 4.30% SENIOR NOTES DUE 2047.  Full Article

AmerisourceBergen to acquire H. D. Smith
Monday, 20 Nov 2017 04:52pm EST 

Nov 20 (Reuters) - AmerisourceBergen Corp ::AmerisourceBergen to acquire H. D. Smith.AmerisourceBergen Corp - deal for ‍$815 million in cash​.AmerisourceBergen Corp - ‍plans to fund acquisition through issuance of new long-term debt​.AmerisourceBergen Corp - ‍acquisition is expected to be slightly accretive to adjusted diluted EPS in fiscal year 2018​.AmerisourceBergen Corp - ‍acquisition expected to achieve full run-rate synergies, be about $0.15 accretive to adjusted EPS in FY 2020​.AmerisourceBergen Corp - ‍company now expects fiscal year 2018 adjusted operating income growth to be in range of 4 percent to 7 percent​.AmerisourceBergen Corp - now sees revenue growth to be in range of 8 percent to 11 percent​ for fiscal year 2018.AmerisourceBergen Corp - ‍reaffirming rest of previously announced fiscal 2018 financial guidance​.AmerisourceBergen - expects fiscal year 2018 pharmaceutical distribution services segment operating income growth in range of 4 percent to 7 percent​.  Full Article

AmerisourceBergen increases dividend 4 percent
Thursday, 9 Nov 2017 09:00am EST 

Nov 9 (Reuters) - Amerisourcebergen Corp ::Increases dividend 4 percent.Increased company's quarterly dividend rate 4 percent to $0.38 per common share from $0.365 per common share​​.  Full Article

AmerisourceBergen, on conf call, says current trends indicate that generic buy side deflation rate has not worsened
Thursday, 2 Nov 2017 12:23pm EDT 

Nov 2 (Reuters) - AmerisourceBergen Corp ::AmerisourceBergen CEO, on conf call, says an aging U.S. patient population continues to "demand" the support of pharmaceutical intervention​.AmerisourceBergen CFO, on conf call - continue to experience headwind from lower Hepatitis C revenues this quarter, consistent with overall U.S. market trends.AmerisourceBergen CFO, on conf call - continue to see strong volume, revenue growth for oncology drugs due to expanded indications of overall market growth.AmerisourceBergen CFO, on conf call says our PharMEDium business experienced an increase in sequential shipping volumes in Q4.AmerisourceBergen CFO, on conf call, says current trends indicate that the generic buy side deflation rate has not worsened.AmerisourceBergen CFO, on conf call, says it is likely that only Q4 will have a full benefit of new pharmacies from Walgreens-Rite Aid deal.AmerisourceBergen CFO, on conf call, says transitioning customer contracts to more "balanced pricing" to offset lower contributions from generics.AmerisourceBergen, on conf call, when asked about Amazon's entry into drug supply chain, says "we haven't really counted Amazon at all yet as a threat".  Full Article

NY A.G. Schneiderman, coalition of AGs expand investigation into opioid crisis
Tuesday, 19 Sep 2017 12:39pm EDT 

Sept 19 (Reuters) - New York A.G. Schneiderman::New York A.G. Schneiderman, bipartisan coalition of AGs expand multistate investigation into opioid crisis.Says served subpoenas to Endo International, Janssen Pharmaceuticals, Teva Pharmaceutical/Cephalon Inc and Allergan.Says Attorneys General have also served a supplemental investigative subpoena on Purdue Pharma.Attorneys General demanded information about distribution practices from AmerisourceBergen, Cardinal Health, McKesson.  Full Article

AmerisourceBergen sets quarterly dividend of $0.365 per share
Thursday, 10 Aug 2017 09:29am EDT 

Aug 10 (Reuters) - AmerisourceBergen Corp ::Sets quarterly dividend of $0.365per share.  Full Article

Amerisourcebergen says have yet to see generic deflation ease from its current high single digits
Thursday, 3 Aug 2017 09:55am EDT 

Aug 3 (Reuters) - Amerisourcebergen Corp ::Says its distribution segment had revenue headwind of about 120 basis points due to lower Hepatitis C sales in the quarter.Says the 2016 june quarter was the last quarter we had instances of impactful generic drug price increases.Says to a lesser degree, we also had a headwind from lower brand inflation in the current quarter.Says for brand inflation, it's likey that inflation rate modelled for FY18 will be at low end or slightly below FY17 year range.Says have yet to see generic deflation ease from its current high single digits.Says at this point, expect the health care environment will be similar in fiscal'18 to this year.Says for 2017, one of the bigger impacts on revenues will just be in brand inflation.  Full Article

Photo

Albertsons to buy Rite Aid as Amazon threat looms

(The Feb. 20 story was corrected to remove a reference to Albertsons dropping IPO plans in 2017 in paragraph 4)